Baker McKenzie impresses with a multidisciplinary team, led by the renowned pharmaceutical and drug advertising law expert Thilo Räpple. Clients from the pharmaceutical and healthcare sectors call upon the team’s expertise. The group is well versed in advising companies, drug manufacturers and medical technology companies on regulatory matters as well as compliance issues pertaining to physician, hospital, pharmacy and food law; this offer is complemented by relevant litigation experience. Recent instructions include matters in connection with telemedical projects in the pharmaceutical and healthcare technology sectors. Transactions and financing rounds constitute further mainstays of the advice offering, which is supported by the competition law expertise of Christian Burholt as well as Marc Gabriel ‘s experience in procurement law matters. Constanze Ulmer-Eilfort (life sciences, IP) joined Peters, Schönberger & Partner in December 2021.

The CMS team is particularly active in advising on regulatory issues, including several recent cooperation projects, and supports major domestic and foreign manufacturers of pharmaceuticals and medical devices as well as manufacturers of medicinal cannabis. Recent growth areas include the advice to healthcare service providers, importers and test center operators on Covid-19-related matters in connection with vaccines, pharmaceuticals and tests, while the expertise in digital healthcare and data protection issues was called upon by start-ups, manufacturers of digital healthcare apps and investors. The team also covers matters at the coporate interface and assists with acquisition and sales transactions, takeovers and share purchases. Practice head Jens Wagner has extensive expertise in the areas of pharmaceuticals, biotechnology, medical devices and dietary supplements, which is regularly requested by various companies in the life sciences sector.

Covington & Burling LLP 's team frequently acts across locations and advises national and international pharmaceutical, biotechnology, medical technology and food companies and, increasingly, associations on pharmaceutical and medical device law as well as on relevant intersections. These are primarly matters pertaining to data protection and compliance as well as transactions, IP and litigation. Due to the close cooperation with the Brussels location, the practice also assists with European matters such as EU legal reform projects in the life sciences sector. Pharmaceutical and medical device law specialist Adem Koyuncu heads the team, he is dually qualified as physician and lawyer.

Gleiss Lutz is a popular address for advising health insurance companies and, increasingly, medical technology and pharmaceutical companies. The team advises on patients rights, social security law and regualtory matters. Growth areas include healthcare compliance and transactional matters, which, in addition to medicinal cannabis, data protection and digitisation issues, form the core of the advice offering. This is complemented by expertise in public procurement and patent law as well as mass proceedings. Thanks to its full-service approach, the practice also covered recent Covid-19-related matters in connection with the procurement and distribution of vaccines. Martin Viciano Gofferje and Reimar Buchner lead the team.

Hengeler Mueller's interdisciplinary approach covers matters at the interface with commercial criminal law and M&A as well as data protection, counsel Susanne Koch is a key contact for the latter. Hospital operators, medical device manufacturers, pharmaceutical dealers and private equity investors instruct the team in connection with traditional regulatory issues pertaining to pharmaceutical and veterinary pharmaceutical law. Expertise in transactions, internal investigations and compliance as well as data protection issues in connection with market entry complement this offer. The team’s interface competencies related to constitutional and commercial administrative law were recently demonstrated in the advice to a hospital operator on Covid-19-related matters. Dirk Uwer (public commercial law, compliance and commercial criminal law) and administrative law and regulatory expert Wolfgang Spoerr are among the key contacts.

Taylor Wessing offers an interdisciplinary as well as cross-locational approach and focuses on traditional pharmaceutical law as well as pharmaceutical advertising and medical device law. The team routinely cooperates with other practices and US law firms. The versatile client base consists of pharmaceutical and biotechnology companies, medical device manufacturers and investors, which are advised on transactions, cooperations and patent proceedings in connection with product and market launches as well as on product liability proceedings and other contentious issues. Growth areas include the support to hospitals on matters pertaining to the Hospital Future Act as well as corona-related digital healthcare issues, particularly in the venture capital sphere. The team is led by IP specialist Anja Lunze and Michael Stein, who is experienced in restructurings, joint ventures and corporate law. The salary partner appointment of Kathleen Munstermann in July 2021 strengthened the team’s regulatory capacities in the transactional space.

Allen & Overy LLP is known for its transactional strength in the healthcare and life sciences sector. The team is led by transaction specialist Alexander Veith and assists companies from the pharmaceutical and biotechnology, medical device, consumer and veterinary health sectors as well as private equity investors. Interface competencies cover data protection law, the digitisation of the healthcare sector and cloud-based matters. Counsel Eda Zhuleku is well versed in regulatory matters pertaining to market entry and reimbursement, while Stephan Neuhaus, who joined the team from Hogan Lovells International LLP in May 2021, is a key contact for contentious IP issues. Joachim Feldges (pharmaceutical industry, patent litigation) left the practice in April 2022 to set up his own firm.

Led by the pharmaceutical and medical device law expert and general practitioner Christian Dierks, Dierks+Company advises well-known companies, start-ups as well as phamaceutical manufacturers, here, the team strengthened its capacities with Steffen Schröder in January 2022 (previously at Bayer AG). Additional experience in project management and IT lead to regular instructions in connection with the development of new medical devices and digital healthcare services. This expertise includes contract design and regulatory issues such as benefit assessments, reimbursement matters, clinical trials and market entry, where the practice frequently acts at the interface to data protection and digitisation. Thanks to the co-founded BioLaw Europe network, the team also assists with cross-border matters.

Friedrich Graf von Westphalen & Partner advises a client portfolio consisting of small and medium-sized German companies as well as international corporations from the pharmaceutical, medical device and biotechnology sectors. The advice offering is equally versatile: Frankfurt-based Sabine Schröter advises hospitals and hospital groups on employment law, while Hendrik Thies in Freiburg assists clients with commercial and corporate law issues, in particular the drafting of cross-border contracts. Additionally, Morton Douglas (also in Freiburg) specialises in pharmacy law and is regularly instructed by pharmacies and pharmacy associations. This offer is complemented by expertise in compliance and data protection. Barbara Mayer, who is experienced in corporate and M&A, joined Advant Beiten in April 2022.

Linklaters‘ healthcare practice follows an interdisciplinary and cross-locational approach in advising companies in the healthcare sector on national and international transactions, restructurings and joint ventures. This expertise at the corporate and M&A interface, managing associate Ruprecht von Maltzahn is a key contact here, is complemented by regulatory capacities pertaining to products, such as clinical studies and market entry, as well as expertise in compliance, product liability and (contentious) IP issues. For the latter, Bolko Ehlgen and head of the global TMT and IP practice, Julia Schönbohm, are the key contacts.

Meisterernst Rechtsanwälte impresses with a dual focus on pharmaceutical and food law. Among the client base are players from the pharmaceutical and medical device sectors, which recently drew on the team’s expertise in competition and pharmaceutical advertising law proceedings, including several landmark proceedings, where Christian Tillmanns frequently took the lead. The practice also acts in an advisory capacity, assisting with distribution, advertising and product launch issues, contract design and compliance as well as regulatory and data protection matters. Additionally, Markus Fuderer has expertise in innovative technologies such as artificial intelligence and 3D printing in the healthcare sector.

Oppenländer Rechtsanwälte's Stuttgart-based team focuses on the segments pharmaceuticals, pharmacies and medical devices and regularly assists with proceedings before the authorities, delimitation and distribution issues as well as matters pertaining to pharmaceutical advertising, competition and food law; the latter frequently relates to the health claims regulation, where Christina Koppe-Zagouras and Katharina Köbler regularly take the lead. Koppe-Zagouras and Köbler jointly head the practice with Timo Kieser. All three act in an advisory capacity as well as in contentious proceedings.

Preu Bohlig & Partner fields Alexander Meier as well as practice head Peter von Czettritz in Munich and offers expertise in all areas of pharmaceutical, competition and cosmetics law, which is requested by pharmaceutical and medical device companies. Daniel Hoppe in Hamburg complements this with patent law expertise. The team regularly advises on the licensing, development and marketing of pharmaceuticals – Meier is a key contact for orphan drugs – as well as on product liability and compliance issues. Von Czettritz is also experienced in third-party opposition proceedings.

GÖRG Partnerschaft von Rechtsanwälten mbB advises private and public clinics, care facilities, manufacturers of medical devices, health insurance companies and investors on pharmacy, pharmaceutical, medical device and hospital law, while the team also acts at the real estate, corporate and employment law interfaces. Administrative and medical law expert Marc Schuffner jointly heads the team with John-Patrick Bischoff, who is experienced in healthcare transactions.  In January 2022, Katharina Landes (health law, IP, IT, data protection) and Markus Beyer (M&A) both made salary partners.

Harmsen Utescher specialises in IP and advises on patent litigation, pharmaceutical advertising law (including litigation) as well as the cosmetics law intersection. The client base includes pharmaceutical companies and manufacturers of medical devices, which the team assists with parallel imports and product launches. This advisory offer reflects the expertise of practice head Rainer Kaase.

Luther Rechtsanwaltsgesellschaft mbH was recently instructed in connection with corona-related regulations such as vaccination requirements and vaccination records. The team is also experienced in M&A and PE transactions, mergers and other corporate and contract law issues, including cooperation and distribution agreements, as well as matters pertaining to the founding of clinics and market entries. This offer is complemented by regulatory expertise in dietary supplements and digital healthcare services. Kuuya Josef Chibanguza (contract, commercial and distribution law) made partner in July 2021. The team is led by Oliver Kairies (Hanover), of counsel Cornelia Yzer (Berlin) and Denis Ullrich (Leipzig).

Noerr combines regulatory and corporate law expertise, particularly in the core areas nursing homes, hospitals, medical care centers and medical devices. Food law specialist Evelyn Schulz took over practice group management from antitrust expert Fabian Badtke (he remains on the team) in August 2022; Schulz is experienced in product compliance and distribution. Thanks to cross-practice cooperation, the team also handles matters in the digital healthcare arena. Isabel Jakobs (product safety law, pharmaceutical and medical device law) made associated partner in January 2022.

PPP Rechtsanwälte covers all aspects of healthcare and medical law in the outpatient and inpatient sector, while the team is also experienced in employment, social security, data protection and tax law. Healthcare institutions are advised on the entire value chain, including formation and licensing, M&A, restructuring and litigation. The practice is led by Andreas Penner , Tanja Koopmann-Röckendorf , André Bohmeier (all three in Düsseldorf), Ute Pittrof (Ingolstadt), Felix Reimer (Heilbronn) and Matthias Wallhäuser (Bergisch Gladbach).

Schmidt, von der Osten & Huber is experienced in medical and health law and advises hospitals, medical and non-medical service providers and funding agencies on a wide array of issues, including employment and corporate law, transactions and contentious proceedings.

Tsambikakis & Partner Rechtsanwälte is renowned for its expertise in medical criminal law. The team represents hospitals, doctors, pharmaceutical and medical device manufacturers in investigative and criminal proceedings and also advises on preventive compliance matters. The team is jointly led by the founder and commercial, tax and medical criminal law specialist Michael Tsambikakis and the medical law and compliance expert Daniela Etterer.